It is a trading private limited company based in Moradabad, Uttar Pradesh, India, established in 2019.
2019 | Moradabad, Uttar Pradesh, India | ActiveNuclomed Pharmaceuticals Private Limited, a active private limited company, was established on 07 October 2019 in Moradabad, Uttar Pradesh, India. Engaging in other wholesale within the trade sector, it holds CIN: U24299UP2019PTC122039. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.00 M.
Its leadership includes Nazrul Islam (Director), Shoiab Khan (Director), Hareswar Borah (Director). Past directors included Syeda Tajneen Ara Begum, Rowsanara Begum. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C60, Part A, Near Police Chowki Jigar Colony, Moradabad, Uttar Pradesh, 244001.
U24299UP2019PTC122039
122039
07 October 2019
₹5.00 M
₹4.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Nuclomed Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nazrul Islam | Director | 07 Oct 2019 | Current |
| Shoiab Khan | Director | 07 Oct 2019 | Current |
| Hareswar Borah | Director | 07 Oct 2019 | Current |
| Robertson Timung | Director | 07 Oct 2019 | Current |
| Syeda Tajneen Ara Begum | Director | 05 Nov 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nuclomed Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 357.82% increase in profit. The company's net worth Soared by an impressive increase of 493.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nuclomed Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nuclomed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nuclomed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuclomed Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nuclomed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Nuclomed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
Syeda Tajneen Ara Begum was appointed as a Director was appointed as a Director on 05 Nov 2019 & has been associated with this company since 6 years 20 days . was recorded as a recent event.
Nazrul Islam was appointed as a Director was appointed as a Director on 07 Oct 2019 & has been associated with this company since 6 years 1 month . was recorded as a recent event.
The activity Shoiab Khan was appointed as a Director was appointed as a Director on 07 Oct 2019 & has been associated with this company since 6 years 1 month . was completed.
The activity Hareswar Borah was appointed as a Director was appointed as a Director on 07 Oct 2019 & has been associated with this company since 6 years 1 month . was completed.
The CIN of Nuclomed Pharmaceuticals Private Limited is U24299UP2019PTC122039.
Nuclomed Pharmaceuticals Private Limited is headquartered at C60, Part A, Near Police Chowki Jigar Colony, Moradabad, Uttar Pradesh, 244001.
Nuclomed Pharmaceuticals Private Limited was incorporated on 07 October 2019.
The current directors of Nuclomed Pharmaceuticals Private Limited are
The primary industry of Nuclomed Pharmaceuticals Private Limited is Trade.
Nuclomed Pharmaceuticals Private Limited is unlisted.
The authorized capital of Nuclomed Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹4.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX